These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8068271)

  • 61. Caretaker Obstreperous Behavior Rating Scale.
    Swearer JM; Drachman DA
    Int Psychogeriatr; 1996; 8 Suppl 3():321-4. PubMed ID: 9154582
    [No Abstract]   [Full Text] [Related]  

  • 62. A balanced stimulation and retreat program for a special care dementia unit.
    Lawton MP; Van Haitsma K; Klapper J
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S133-8. PubMed ID: 8068253
    [No Abstract]   [Full Text] [Related]  

  • 63. Development of simple cognitive function measures in a community dwelling population of elderly in Spain.
    Zunzunegui MV; Gutiérrez Cuadra P; Béland F; Del Ser T; Wolfson C
    Int J Geriatr Psychiatry; 2000 Feb; 15(2):130-40. PubMed ID: 10679845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving office detection of asymptomatic dementia.
    Raab MF; Anstadt SP
    J Am Geriatr Soc; 2011 Oct; 59(10):1975-6. PubMed ID: 22091518
    [No Abstract]   [Full Text] [Related]  

  • 65. The evolution of specialized dementia care: the relationship between research and program planning.
    Reingold J; Werner B
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S126-32. PubMed ID: 8068252
    [No Abstract]   [Full Text] [Related]  

  • 66. [Quality of life of the aged. Findings and intervention approaches].
    Kruse A
    Z Gerontol Geriatr; 2003 Dec; 36(6):419-20. PubMed ID: 14685730
    [No Abstract]   [Full Text] [Related]  

  • 67. Psychometric characteristics of the minimum data set II: validity.
    Lawton MP; Casten R; Parmelee PA; Van Haitsma K; Corn J; Kleban MH
    J Am Geriatr Soc; 1998 Jun; 46(6):736-44. PubMed ID: 9625190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-home assessment of dementia by nurses: experience using the CERAD evaluations. Consortium to Establish a Registry for Alzheimer's Disease.
    Trapp-Moen B; Tyrey M; Cook G; Heyman A; Fillenbaum GG
    Gerontologist; 2001 Jun; 41(3):406-9. PubMed ID: 11405439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Item response theory reveals variability of functional impairment within clinical dementia rating scale stages.
    Miller TM; Balsis S; Lowe DA; Benge JF; Doody RS
    Dement Geriatr Cogn Disord; 2011; 32(5):362-6. PubMed ID: 22311305
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Neuropsychological examination in evaluating dementia].
    Monsch AU
    Praxis (Bern 1994); 1997 Aug; 86(35):1340-2. PubMed ID: 9381025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Baseline instrumental activities of daily living and incident dementia.
    Regal P; Heatherington E
    J Am Geriatr Soc; 2012 Jun; 60(6):1189-90. PubMed ID: 22691000
    [No Abstract]   [Full Text] [Related]  

  • 72. The Psychogeriatric Assessment Scales: a multi-dimensional alternative to categorical diagnoses of dementia and depression in the elderly.
    Jorm AF; Mackinnon AJ; Henderson AS; Scott R; Christensen H; Korten AE; Cullen JS; Mulligan R
    Psychol Med; 1995 May; 25(3):447-60. PubMed ID: 7480426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Adaptation of a dementia test for use in visually handicapped persons exemplified by SIDAM (Structured Interview for the Diagnosis of Alzheimer disease, Multi-Infarct Dementia and Dementias of other Etiology)].
    Busse A; Aurich C; Riedel-Heller S; Matschinger H; Angermeyer MC
    Z Gerontol Geriatr; 2002 Feb; 35(1):21-31. PubMed ID: 11974513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of the 10/66 Dementia Research Group's 10/66 Dementia diagnosis in Iran.
    Nozari N; Ferri CP; Farin F; Noroozian M; Salehi M; Seyedian M; Prince M
    Int Psychogeriatr; 2009 Jun; 21(3):604-5. PubMed ID: 19216821
    [No Abstract]   [Full Text] [Related]  

  • 75. Problems in measuring and interpreting cognitive decline.
    Kukull WA
    J Am Geriatr Soc; 1998 Dec; 46(12):1578-9. PubMed ID: 9848823
    [No Abstract]   [Full Text] [Related]  

  • 76. Diagnostic criteria for vascular dementia.
    Hillam J; Graham N
    Age Ageing; 1996 Sep; 25(5):414-5. PubMed ID: 8921155
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluating screening tests for dementia and cognitive impairment in a heterogeneous population in the presence of verification bias.
    Donald A; Van Til L
    Int Psychogeriatr; 2001; 13 Supp 1():203-14. PubMed ID: 11892968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alzheimer neuropathology in nondemented aging: keeping mind over matter.
    Lippa CF; Morris JC
    Neurology; 2006 Jun; 66(12):1801-2. PubMed ID: 16801639
    [No Abstract]   [Full Text] [Related]  

  • 79. [Assessment of mild cognitive impairment and dementia in epidemiologic studies. An overview on the current state of research in Germany].
    Then FS; Luck T; Jacobi F; Berger K; Weyerer S; Grabe HJ; Busch MA; Wagner M; Riedel-Heller SG
    Psychiatr Prax; 2013 May; 40(4):183-91. PubMed ID: 23564357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of agitation.
    Cohen-Mansfield J
    Int Psychogeriatr; 1996; 8(2):233-45. PubMed ID: 8994894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.